Skip to main content
Phase 3 trial supports topical JAK inhibitor for AD in young children
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Phase 3 trial supports topical JAK inhibitor for AD in young children
User login
Username
Password
Reset your password
Concept
Lead
score
Dermatitis
1
1
Child
0
0.98
Pain Management
0
0.85
Adolescent Medicine
0
0.99
Pediatric Dermatology
0
0.22
Atopic Dermatitis
0
0.97
California
0
0.13
Plasma
0
0.13
Pruritus
0
0.13
Rheumatoid Arthritis
0
0.09
Anti-inflammatory Agents
0
0.06
Arthritis
0
0.06
Eczema
0
0.06
Europe
0
0.06
Hemoglobin
0
0.06
Hospital
0
0.06
Myelosuppression
0
0.06
Neutrophils
0
0.06
Pain
0
0.06
Severity Index
0
0.06
Specialty
Lead
score
Dermatology
1
1
Family Medicine/Primary Care
0
0.9
Pediatrics
0
0.8
Allergy & Clinical Immunology
0
0.7
Edit Tags